SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
Level 8, 210 George Street, Sydney NSW 2000
Tel : +61 2 9290 9600 or 1300 737 760The liquidator reports on their activities during the creditors' voluntary winding-up of the company. | 27/08/2024 |
company is now called A.C.N. 167 748 843 LIMITED | 05/11/2023 |
delisted following failure to pay the annual ASX listing fees per Listing Rule 17.15 | 29/08/2022 |
we understand the company failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023 | 29/08/2022 |
Under Listing Rule 17.6, an entity (if not already suspended) that had not paid its annual listing fees by close of business on Friday, 19 August 2022 would have its securities suspended from Official Quotation before the commencement of trading on Monday, 22 August 2022. The following entity has failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023, and each entity's securities are already suspended from quotation. Under Listing Rule 17.15, any entity that has not paid its annual listing fees as required by Listing Rule 16.5 by 5.00 pm AEST on Friday, 26 August 2022 will be removed from the Official List with effect from the close of trading on Friday, 26 August 2022. | 22/08/2022 |
Mark Robinson, Antony Resnick and Riad Tayeh were appointed Joint and Several Administrators of the above company on 10 March 2022. On 11 July 2022 creditors resolved to place the company into liquidation. The likelihood of a return to shareholders is remote and depends primarily on the total amount of creditors' claims and our investigations into the Company's financial affairs. | 29/07/2022 |
this company, now in liquidation, is called ACN 167 748 843 - apparently the company's business was sold around the same time a change of company name occurred - (3 June 2022 - courtesy of AFR "Arrotex Pharmaceuticals, backed by AFR Rich Lister Dennis Bastas, has snapped up Farmaforce from the administrators of failed controversial biotech iQ Group Global. The administrators at De Vries Tayeh also confirmed that offers had been made for a yacht that the biotechnology outfit had bought for $1.2 million.") | 19/07/2022 |
Mark Robinson and Anthony Resnick of de Vries Tayeh are appointed liquidators | 11/07/2022 |
The company has entered voluntary administration with the directors appointing Mark Robinson, Anthony Resnick, and Riad Tayeh of de Vries Tayeh as joint and several voluntary administrators. | 11/03/2022 |
The audit review of its half-year report for the six months ended 31 December 2021 has not yet been completed. The Company is working with its auditor to complete the review and the Company expects to release its audited halfyear report on Monday 7 March 2022. | 01/03/2022 |
The company's securities will be suspended from official quotation from the commencement of trading today, 1 March 2022, following its failure to lodge the relevant periodic report by the due date. | 01/03/2022 |
listed entity carried for record purposes only | 27/10/2015 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 12/12/2020 | Con Tsigounis | -220,000 | $0.085 | $18,700.00 |
| 11/12/2020 | George Elias | -220,000 | $0.085 | $18,700.00 |
| 11/12/2020 | Harry Simeonidis | -108,471 | $0.085 | $9,220.00 |
| 11/12/2020 | Con Tsigounis | -220,000 | $0.085 | $18,700.00 |
| 30/11/2020 | Harry Simeonidis | -55,800 | $0.085 | $4,743.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Vincenzo Milazzo | Non Exec Chairman | 17/06/2021 |
| Terence Rego | Non Exec Director | 22/03/2021 |
| Con Tsigounis | Director | 24/06/2015 |
| Kosmas Dimitriou | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
